Inhibition of glutaminolysis in combination with other therapies to improve cancer treatment is a research paper published in Current Opinion in Chemical Biology (2021). On theSindex it has a DataRank of 0. It has been cited 75 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Ministry of Science and Technology, Taiwan
Grant: 109-2314-B-038-021-MY3
NIH
Grant: R01-CA193895
NIH
Grant: R01-CA112314
Taipei Medical University
Grant: 108-5403-003-112
NCI NIH HHS
Grant: R01 CA112314
NCI NIH HHS
Grant: R01 CA193895
National Institutes of Health
Grant: 5R01CA112314-02
Probing the Connections between Monosaccharide Analogs, Sialic Acid Metabolism, a
National Institutes of Health
Grant: 5R01CA193895-05
Glutaminase Inhibitor Drug Discovery and Nanoparticle-Based Delivery for Pancreatic Cancer Therapy
Trust for Mutual Understanding
FWCI
3.93
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals